Back to Peptides

NAD+

Extensively Studied

Essential Cellular Coenzyme & Anti-Aging Therapy

Dose IV: 250-1000mg; IM/SubQ: 100-500mg; Intranasal: 25-50mg; Oral precursors: 100-500mg NMN/NR
Frequency IV: 1-2x weekly; IM/SubQ: 2-3x weekly; Intranasal: 1-2x daily; Oral: daily
Cycle 4-12 weeks; IV therapy requires medical supervision
Storage Refrigerate at 2-8°C; protect from light

NAD+ is a crucial coenzyme found in every cell, involved in energy generation and cellular maintenance that naturally declines with age. Supplementation may support cellular health, boost energy, enhance cognitive function, and promote longevity through multiple delivery methods.

Mechanism of Action

Direct delivery to bloodstream ensures maximum cellular availability for energy production via ATP synthesis, DNA repair through PARP activation, and sirtuin-mediated longevity pathways. Supports mitochondrial function and metabolic homeostasis.

Key Benefits

  • Restores mitochondrial function and ATP synthesis
  • Enhances glucose and fat metabolism
  • Improves oxygen utilization and endurance
  • Activates DNA repair mechanisms
  • Supports longevity pathways via sirtuins
  • Improves mental clarity and focus
Molecular Weight
663.43 Da
Type
Coenzyme
Amino Acid Sequence
C21H27N7O14P2

Complex or non-standard sequence format

Energy & Metabolism

  • Cellular Energy Production

    Restores NAD+ levels for optimal ATP synthesis

  • Metabolic Optimization

    Enhances glucose and fat metabolism

  • Exercise Performance

    Improves oxygen utilization and endurance

Anti-Aging

  • DNA Repair

    Activates PARP enzymes for genomic stability

  • Sirtuin Activation

    Supports longevity pathways

  • Cellular Senescence Reduction

    May help clear senescent cells

Neurological

  • Cognitive Enhancement

    Improves mental clarity and focus

  • Neuroprotection

    Supports neuronal health and function

Highest bioavailability (100%) via IV, IM, or subcutaneous injection.

GoalDoseFrequencyRoute
IV Infusion250-1000mg1-2x weeklyIntravenous
IM/SubQ100-500mg2-3x weeklyIntramuscular or Subcutaneous
BPC-157

Enhanced cellular repair and energy production

synergistic
TB-500

Complementary tissue regeneration effects

synergistic
Tirzepatide

Supports metabolic pathways enhanced by GLP-1 agonists

compatible
Ipamorelin

Growth hormone pathways benefit from improved energy metabolism

synergistic
CJC-1295

Enhanced recovery and anti-aging effects

compatible
Alcohol

Alcohol significantly reduces NAD+ levels and effectiveness

avoid
Week 1-2

Initial energy improvements and mental clarity

Week 3-4

Enhanced physical performance and recovery

Week 5-8

Sustained energy levels and improved sleep quality

Week 9-12

Optimized metabolic function and cognitive benefits

Common Side Effects

  • Mild flushing during IV infusion
  • Temporary nausea

Stop Signs - Discontinue if:

  • Severe injection site reactions or infection signs
  • Persistent nausea or gastrointestinal distress
  • Unusual fatigue or weakness
  • Allergic reactions (rash, swelling, breathing difficulty)

Contraindications

  • IV administration requires medical supervision
  • Avoid alcohol during treatment
  • Maintain consistent dosing schedule

Good Signs

  • Clear, colorless solution (injectable)
  • Proper refrigeration at 2-8°C
  • Sterile injection technique
  • Third-party tested for purity

Warning Signs

  • Use reconstituted solution within 28 days

Bad Signs

  • Cloudy or discolored solution indicates contamination
  • Room temperature storage degrades NAD+ rapidly
  • NAD+ Restoration Strategies in Clinical Practice
    Regenerative Medicine Journal (2024)

    Review of clinical applications and restoration strategies

  • Clinical Evidence for NAD+ Therapeutic Applications
    Clinical Interventions in Aging (2024)

    Evidence for anti-aging and therapeutic applications

  • NAD+ Precursor Safety and Efficacy Meta-Analysis
    Nature Metabolism (2024)

    Meta-analysis of safety and efficacy data

  • Intranasal NAD+ Delivery for Neurological Applications
    Neuropharmacology Research (2023)

    Demonstrated efficacy of intranasal delivery for brain access

Disclaimer

This information is for educational and research purposes only. Consult a healthcare professional before use.